Business Wire

NESSUM-ALLIANCE

21.5.2024 10:01:27 CEST | Business Wire | Press release

Share
Connecting the Future with Any Media Communication: NESSUM Alliance's Groundbreaking Technology Incorporated in International Standard IEEE 1901!

In a groundbreaking stride toward advancing communication standards in the digital age, the NESSUM Alliance is proud to announce the release of the IEEE 1901c standard on May 15th. This transformative standard, created from the collaborative efforts of NESSUM's esteemed members, now stands poised to redefine connectivity paradigms worldwide, under the rebranded banner of NESSUM.

With the introduction of IEEE 1901c, formerly known as 'HD-PLC,' NESSUM introduces many new and unparalleled features:

  • Long-Distance Communication: Spanning several kilometers, NESSUM enables a new era of expansive reach.
  • Broadband Communication: Operating in the Mbps class, this standard ensures seamless transmission of data across networks.
  • IP Compatibility: Using standardized Internet Protocol (IP), NESSUM seamlessly integrates with existing infrastructures.
  • Topology-Free Configuration: Facilitating flexible networking, NESSUM overcomes conventional constraints of network configurations.
  • Safety and Security: Prioritizing network and user safety, NESSUM ensures robust and secure communication channels.

Besides high-speed communication on any wire, NESSUM technology also enables the transmission of weak radio signals, facilitating short-range wireless communication applications, including underwater environments. This makes it a truly versatile solution for any media.

The IEEE began the development of the any medium communication standard for IoT applications as IEEE P1901c in May 2022, including the adoption of the Wavelet OFDM method - one of the advanced feature sets of NESSUM's technological advantages compare to other (power line) solutions. After months of effort and refinement, IEEE 1901c attained formal approval in February of this year, marking a monumental leap forward in communication standards.

Mr. Jean-Philippe Faure, Chair of the IEEE 1901WG, lauded the contributions of NESSUM Alliance's expert members, affirming, "This new standard expands the application range of powerline communication to various existing lines and supports low-power radio, opening up new possibilities for high-speed short-range wireless communication."

Agreeing to this sentiment, Mr. Hiroshi Saijo, Head of Business Development & Strategy at Panasonic Holdings Corporation, articulated a shared vision of global proliferation, stating, "We aim to spread this IoT communication standard worldwide as an international standard, not only in products but also in applications."

Mr. Keishi Kajiwara, Director of the Communication Business Division at MegaChips Corporation expressed eager anticipation for market expansion and collaborative endeavors with the new standard, NESSUM's pivotal role in driving innovation.

Mr. Christopher Trabold, CTO and Business Development Leader for Asset Monitoring and Communication at General Electric Vernova, emphasized the burgeoning demand for powerline communication with the digitalization of power infrastructure, signaling a promising trajectory for IEEE 1901c.

IEEE 1901c's transformative capabilities extend to long-distance powerline communication, now covering the several hundred kHz band as NBPLC through innovative resampling. This evolutionary leap finds resonance in diverse sectors, from medium-voltage system control to smart meters, with new applications in Asia and beyond.

Mr. Markus Rindchen, Head of Technology Management at Power Plus Communications AG, pointed out the indispensable role of NESSUM in Germany's Smart Meter Gateway business, underscoring its essential role for the mass roll-out.

Mr. Tomislav Drenski, Marketing Manager at Socionext Europe GmbH is excited to promote the new NESSUM ICs. These advanced ICs offer unique features such as high speed, stable and secure long-distance communication, which surpass other power line solutions available in the market.

With a strong long-term commitment to meet evolving market demands and continuously develop innovation in the IoT landscape, the NESSUM Alliance promotes and supports Any Media communications being inter-operable worldwide. Through a multifaceted approach encompassing webinars, seminars, exhibitions, and extensive promotional activities, the alliance is confident and certain to drive future state-of-the-art solutions with increased compatibility, and lead international standardization efforts.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240521360203/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release

Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release

Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye